Genetic Epidemiology, Psychiatric Genetics, Asthma Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
25744370
TITLE
Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1.
ABSTRACT
BACKGROUND NlmCategory: BACKGROUND
No opioid receptor, mu 1 (OPRM1) gene polymorphisms, including the functional single nucleotide polymorphism (SNP) rs1799971, have been conclusively associated with heroin/other opioid addiction, despite their biological plausibility. We used evidence of polymorphisms altering OPRM1 expression in normal human brain tissue to nominate and then test associations with heroin addiction.
METHODS NlmCategory: METHODS
We tested 103 OPRM1 SNPs for association with OPRM1 messenger RNA expression in prefrontal cortex from 224 European Americans and African Americans of the BrainCloud cohort. We then tested the 16 putative cis-expression quantitative trait loci (cis-eQTL) SNPs for association with heroin addiction in the Urban Health Study and two replication cohorts, totaling 16,729 European Americans, African Americans, and Australians of European ancestry.
RESULTS NlmCategory: RESULTS
Four putative cis-eQTL SNPs were significantly associated with heroin addiction in the Urban Health Study (smallest p = 8.9 × 10(-5)): rs9478495, rs3778150, rs9384169, and rs562859. Rs3778150, located in OPRM1 intron 1, was significantly replicated (p = 6.3 × 10(-5)). Meta-analysis across all case-control cohorts resulted in p = 4.3 × 10(-8): the rs3778150-C allele (frequency = 16%-19%) being associated with increased heroin addiction risk. Importantly, the functional SNP allele rs1799971-A was associated with heroin addiction only in the presence of rs3778150-C (p = 1.48 × 10(-6) for rs1799971-A/rs3778150-C and p = .79 for rs1799971-A/rs3778150-T haplotypes). Lastly, replication was observed for six other intron 1 SNPs that had prior suggestive associations with heroin addiction (smallest p = 2.7 × 10(-8) for rs3823010).
CONCLUSIONS NlmCategory: CONCLUSIONS
Our findings show that common OPRM1 intron 1 SNPs have replicable associations with heroin addiction. The haplotype structure of rs3778150 and nearby SNPs may underlie the inconsistent associations between rs1799971 and heroin addiction.
Copyright 2015 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
DATE PUBLISHED
2015 Oct 1
HISTORY
PUBSTATUS PUBSTATUSDATE
received 2014/10/13
revised 2014/12/18
accepted 2015/01/08
aheadofprint 2015/01/29
entrez 2015/03/07 06:00
pmc-release 2016/10/01 00:00
pubmed 2015/03/07 06:00
medline 2015/03/07 06:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Hancock DB Hancock Dana B DB Behavioral Health Epidemiology Program, Behavioral Health and Criminal Justice Division, Research Triangle Institute (RTI) International, St. Louis, Missouri.. Electronic address: dhancock@rti.org.
Levy JL Levy Joshua L JL Research Computing Division, RTI International, Research Triangle Park, North Carolina, St. Louis, Missouri.
Gaddis NC Gaddis Nathan C NC Research Computing Division, RTI International, Research Triangle Park, North Carolina, St. Louis, Missouri.
Glasheen C Glasheen Cristie C Behavioral Health Epidemiology Program, Behavioral Health and Criminal Justice Division, Research Triangle Institute (RTI) International, St. Louis, Missouri.
Saccone NL Saccone Nancy L NL Department of Genetics, Washington University in St. Louis, St. Louis, Missouri.
Page GP Page Grier P GP Center for Public Health Genomics, RTI International, Atlanta, Georgia.
Hulse GK Hulse Gary K GK School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Western Australia, Australia.
Wildenauer D Wildenauer Dieter D School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Western Australia, Australia.
Kelty EA Kelty Erin A EA School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Western Australia, Australia.
Schwab SG Schwab Sibylle G SG Department of Psychiatry and Psychotherapy, University of Erlangen-Nuremberg, Erlangen, Germany.; Faculty of Science, Medicine, and Health, University of Wollongong, Wollongong, New South Wales.
Degenhardt L Degenhardt Louisa L National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
Martin NG Martin Nicholas G NG Queensland Institute of Medical Research Berghofer Medical Research Institute, Brisbane, Queensland.
Montgomery GW Montgomery Grant W GW Queensland Institute of Medical Research Berghofer Medical Research Institute, Brisbane, Queensland.
Attia J Attia John J Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales.; Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales.
Holliday EG Holliday Elizabeth G EG Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales.; Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales.
McEvoy M McEvoy Mark M Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales.; Public Health Research Program, Biomarker Discovery and Information-Based Medicine, Hunter Medical Research Institute, Newcastle, New South Wales.
Scott RJ Scott Rodney J RJ Center for Bioinformatics, Biomarker Discovery and Information-Based Medicine, Hunter Medical Research Institute, Newcastle, New South Wales.; School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales.; Division of Genetics, Hunter Area Pathology Service, Newcastle, New South Wales, Australia.
Bierut LJ Bierut Laura J LJ Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri.
Nelson EC Nelson Elliot C EC Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri.
Kral AH Kral Alex H AH Urban Health Program, Behavioral Health and Criminal Justice Division, RTI International, San Francisco, California.
Johnson EO Johnson Eric O EO Fellow Program and Behavioral Health and Criminal Justice Division, RTI International, Research Triangle Park, North Carolina.
INVESTIGATORS
JOURNAL
VOLUME: 78
ISSUE: 7
TITLE: Biological psychiatry
ISOABBREVIATION: Biol. Psychiatry
YEAR: 2015
MONTH: Oct
DAY: 1
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 1873-2402
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: Biol Psychiatry
COUNTRY: United States
ISSNLINKING: 0006-3223
NLMUNIQUEID: 0213264
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites Drug Alcohol Depend. 2000 Jan 1;57(3):193-202 10661670
Cites Am J Psychiatry. 2003 Apr;160(4):687-95 12668357
Cites Am J Epidemiol. 2003 May 15;157(10):915-22 12746244
Cites Am J Hum Genet. 2004 Apr;74(4):765-9 14997420
Cites J Neurochem. 2004 May;89(3):553-60 15086512
Cites Br J Addict. 1992 Nov;87(11):1527-36 1458032
Cites Am J Med Genet. 1996 Sep 20;67(5):473-7 8886164
Cites Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9608-13 9689128
Cites Arch Gen Psychiatry. 1998 Nov;55(11):967-72 9819064
Cites Drug Alcohol Depend. 1998 Nov 1;52(3):231-41 9839149
Cites Am J Addict. 1999 Spring;8(2):148-60 10365195
Cites Bioinformatics. 2005 Jan 15;21(2):263-5 15297300
Cites Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):105-9 15558714
Cites Am J Psychiatry. 2005 Aug;162(8):1403-13 16055761
Cites Heredity (Edinb). 2005 Sep;95(3):221-7 16077740
Cites J Biol Chem. 2005 Sep 23;280(38):32618-24 16046395
Cites Hum Mol Genet. 2006 Mar 15;15(6):807-19 16476706
Cites Drug Alcohol Depend. 2006 Jul 27;83(3):262-8 16387451
Cites Biol Psychiatry. 2006 Sep 15;60(6):650-8 16997002
Cites Drug Alcohol Depend. 2007 Oct 8;90(2-3):159-65 17416470
Cites J Neurochem. 2007 Oct;103(1):77-87 17877633
Cites Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):877-84 17503481
Cites Am J Hum Genet. 2008 Feb;82(2):453-63 18252225
Cites Genes Brain Behav. 2008 Oct;7(7):720-9 18518925
Cites Nat Genet. 2009 Feb;41(2):216-20 19122664
Cites Hum Mol Genet. 2009 Mar 15;18(6):1037-51 19103668
Cites Am J Hum Genet. 2009 May;84(5):581-93 19426955
Cites PLoS Genet. 2010 Apr;6(4):e1000888 20369019
Cites Hum Mol Genet. 2010 Sep 1;19(17):3482-8 20601676
Cites Psychiatr Genet. 2010 Oct;20(5):207-14 20520587
Cites Bioinformatics. 2010 Sep 15;26(18):2336-7 20634204
Cites Kidney Int. 2010 Oct;78(7):698-704 20668430
Cites Mol Psychiatry. 2013 Mar;18(3):340-6 22212596
Cites JAMA Psychiatry. 2013 Mar;70(3):325-33 23303482
Cites ScientificWorldJournal. 2013;2013:748979 23533358
Cites Hum Genet. 2013 May;132(5):509-22 23334152
Cites Pharmacogenomics. 2013 May;14(7):813-24 23651028
Cites Neuropharmacology. 2014 Jan;76 Pt B:204-17 24035914
Cites Addict Biol. 2014 Jan;19(1):111-21 22500942
Cites Biol Psychiatry. 2014 Jul 1;76(1):66-74 24143882
Cites Addiction. 2014 Aug;109(8):1320-33 24661272
Cites Nature. 2010 Oct 28;467(7319):1061-73 20981092
Cites Hum Mol Genet. 2010 Dec 1;19(23):4745-57 20833654
Cites Int J Epidemiol. 2010 Dec;39(6):1452-63 20056765
Cites Am J Hum Genet. 2011 Jan 7;88(1):6-18 21194676
Cites J Hum Genet. 2011 Feb;56(2):147-55 21160491
Cites Epidemiology. 2011 Sep;22(5):746-7 21811115
Cites PLoS One. 2011;6(9):e24395 21949713
Cites Nat Rev Neurosci. 2011 Nov;12(11):652-69 22011681
Cites Nature. 2011 Oct 27;478(7370):519-23 22031444
Cites Nucleic Acids Res. 2012 Jan;40(Database issue):D930-4 22064851
Cites Hum Genet. 2012 Jan;131(1):77-85 21706340
Cites Am J Hum Genet. 2012 Feb 10;90(2):260-72 22305529
Cites PLoS One. 2012;7(4):e35333 22509407
Cites PLoS Genet. 2012;8(4):e1002639 22532805
Cites Mol Vis. 2012;18:1083-92 22605921
Cites Nature. 2012 Sep 6;489(7414):57-74 22955616
Cites Hum Mol Genet. 2012 Nov 1;21(21):4751-60 22875838
Cites Genome Biol. 2012;13(9):R49 22950968
Cites PLoS One. 2012;7(11):e50610 23226329
Cites Hum Mol Genet. 2013 Jan 1;22(1):184-201 23001569
Cites Nucleic Acids Res. 2013 Jan;41(Database issue):D110-7 23161672
CommentIn Biol Psychiatry. 2015 Oct 1;78(7):439-40 26360547
GRANTS
GRANTID AGENCY COUNTRY
HHSN268200782096C NHGRI NIH HHS United States
HHSN268200782096C PHS HHS United States
M01 RR165001 NCRR NIH HHS United States
M01RR165001 NCRR NIH HHS United States
N01 HG065403 NHGRI NIH HHS United States
N01 HG65403 NHGRI NIH HHS United States
P01 CA033619 NCI NIH HHS United States
P01 CA089392 NCI NIH HHS United States
P01 CA089392 NCI NIH HHS United States
P01 CA33619 NCI NIH HHS United States
P50 CA084724 NCI NIH HHS United States
P50 CA084724 NCI NIH HHS United States
P50 CA093459 NCI NIH HHS United States
P50 CA093459 NCI NIH HHS United States
P50 CA097007 NCI NIH HHS United States
P50 CA097007 NCI NIH HHS United States
P50 DA019706 NIDA NIH HHS United States
P50 DA019706 NIDA NIH HHS United States
P50CA093459 NCI NIH HHS United States
R01 AA011330 NIAAA NIH HHS United States
R01 AA011330 NIAAA NIH HHS United States
R01 CA063464 NCI NIH HHS United States
R01 CA133996 NCI NIH HHS United States
R01 CA133996 NCI NIH HHS United States
R01 CA63464 NCI NIH HHS United States
R01 DA013423 NIDA NIH HHS United States
R01 DA013423 NIDA NIH HHS United States
R01 DA017305 NIDA NIH HHS United States
R01 DA019963 NIDA NIH HHS United States
R01 DA025888 NIDA NIH HHS United States
R01 DA026141 NIDA NIH HHS United States
R01 DA026141 NIDA NIH HHS United States
R01 DA026911 NIDA NIH HHS United States
R01 DA036583 NIDA NIH HHS United States
R01 DA17305 NIDA NIH HHS United States
R01 ES011740 NIEHS NIH HHS United States
R01 ES011740 NIEHS NIH HHS United States
R01 HL109031 NHLBI NIH HHS United States
R01 NS045012 NINDS NIH HHS United States
R01 NS45012 NINDS NIH HHS United States
R01DA036583 NIDA NIH HHS United States
R01NS45012 NINDS NIH HHS United States
R33 DA027486 NIDA NIH HHS United States
R33 DA027486 NIDA NIH HHS United States
R33DA027486 NIDA NIH HHS United States
R37 CA054281 NCI NIH HHS United States
R37 CA54281 NCI NIH HHS United States
RC2 CA148085 NCI NIH HHS United States
RC2 CA148085 NCI NIH HHS United States
U01 CA098758 NCI NIH HHS United States
U01 CA136792 NCI NIH HHS United States
U01 CA136792 NCI NIH HHS United States
U01 CA98758 NCI NIH HHS United States
U01 HG004422 NHGRI NIH HHS United States
U01 HG004422 NHGRI NIH HHS United States
U01 HG004436 NHGRI NIH HHS United States
U01 HG004436 NHGRI NIH HHS United States
U01 HG004438 NHGRI NIH HHS United States
U01 HG004438 NHGRI NIH HHS United States
U01 HG004446 NHGRI NIH HHS United States
U01 HG004446 NHGRI NIH HHS United States
U01 HG004726 NHGRI NIH HHS United States
U01 HG004726 NHGRI NIH HHS United States
U01 HG004789 NHGRI NIH HHS United States
U01G004446 PHS HHS United States
U01HG004438 NHGRI NIH HHS United States
U10 AA008401 NIAAA NIH HHS United States
U10 AA008401 NIAAA NIH HHS United States
X01 HG005274 NHGRI NIH HHS United States
X01HG005274 NHGRI NIH HHS United States
GENERAL NOTE
KEYWORDS
KEYWORD
Genetic association study
Heroin
Multiancestry
OPRM1
Opioid
Prefrontal cortex
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's
OTHERID SOURCE
NIHMS669095 [Available on 10/01/16] NLM
PMC4519434 [Available on 10/01/16] NLM